Comparison of Data Obtained by Echocardiography and Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2006 by Assistance Publique - Hôpitaux de Paris.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Assistance Publique - Hôpitaux de Paris
Information provided by:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00315783
First received: April 17, 2006
Last updated: NA
Last verified: April 2006
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Compare data (structural and functional) obtained by transthoracic rest echocardiography and magnetic resonance imaging (with gadolinium) in 30 patients with hypertrophic cardiomyopathy
| Condition |
|---|
|
Hypertrophic Cardiomyopathy |
| Study Type: | Observational |
| Study Design: | Additional Descriptors: Convenience Sample Observational Model: Natural History Time Perspective: Cross-Sectional Time Perspective: Retrospective/Prospective |
| Official Title: | Comparison of Data Obtained by Echocardiography and Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy |
Resource links provided by NLM:
Genetics Home Reference related topics:
familial hypertrophic cardiomyopathy
supravalvular aortic stenosis
U.S. FDA Resources
Further study details as provided by Assistance Publique - Hôpitaux de Paris:
| Estimated Enrollment: | 30 |
| Study Start Date: | April 2006 |
| Estimated Study Completion Date: | June 2006 |
All data from consecutive patients with HCM explored by 2D-echo or MRI in our institution will be analyzed blindly by a senior echocardiographist and a senior radiologist to highlights the respective interest of each of these examinations for the detection of structural or functional abnormalities in HCM.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Hypertrophic cardiomyopathy
- Age > 18 years
Exclusion Criteria:
- Pregnancy
- Pacemaker
- IACD
- Allergy to gadolinium
- Secondary hypertrophy
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00315783
Contacts
| Contact: Albert A HAGEGE, MD, PhD | 33 1 56093713 | hagege@club-internet.fr |
Locations
| France | |
| Hopital Européen Georges Pompidou | Recruiting |
| Paris, France, 75015 | |
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
| Principal Investigator: | Albert A HAGEGE, Md, PhD | Hopital Européen Georges Pompidou, Paris-FR |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00315783 History of Changes |
| Other Study ID Numbers: | 2006102 |
| Study First Received: | April 17, 2006 |
| Last Updated: | April 17, 2006 |
| Health Authority: | France: National Ethics Committee |
Keywords provided by Assistance Publique - Hôpitaux de Paris:
|
hypertrophic cardiomyopathy echocardiography magnetic resonance imaging |
Additional relevant MeSH terms:
|
Cardiomyopathy, Hypertrophic Hypertrophy Cardiomyopathies Heart Diseases Cardiovascular Diseases |
Aortic Stenosis, Subvalvular Aortic Valve Stenosis Heart Valve Diseases Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on May 23, 2013